Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death (COMPER)

June 13, 2017 updated by: University Hospital, Rouen

Comparative Evaluation of IRM and Autopsy in the Evaluation of Intra Uterine Fetal Death.

Fetal intra uterine death is a rare event (incidence 2/1000 births) , unexpected and psychologically painful for the couple and the healthcare team. In this difficult context, it is essential to understand the etiology of death to guide the management of subsequent pregnancies. Among the investigations, foetopathologic examination is essential, but the examination of the brain is not possible in more than half of the cases due to the cerebral maceration due to the incompressible delay between death and expulsion.

The use of MRI as a diagnostic tool fetal post- mortem " virtual autopsy " performed before expulsion of the fetus is interesting because it would permit to obtain a macroscopic examination of the fetal brain, archivable, and a gain concerning the diagnosis. Thus, a normal MRI will exclude cerebral anatomical abnormality , stroke or bleeding . If MRI abnormalities are found , it will not only guide the foetopathologic review, but mainly to guide the etiology . On the other hand , it is a non-invasive tool and acceptability by the couple would be better than autopsy which is often refused by the couple in this difficult psychological context.

In this study , MRI will be given in addition to conventional autopsy in the painful waiting time between the time of diagnosis of death and expulsion without delaying care . If this study is validated , MRI may be systematically proposed in this indication or alternative to autopsy when it will be refused by the parents.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France, 76000
        • CHU Hôpitaux de Rouen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patient for which he was diagnosed with intra uterine death confirmed by ultrasound
  • Mono fetal pregnancy,
  • Term: 24 to 42 weeks' gestation
  • Age> 18 years
  • Patient having readen the letter of information and signed the consent.

Exclusion Criteria:

  • Contraindication to MRI (heart valve, pacemaker, neurosurgical clips, claustrophobia, intraocular metallic foreign bodies)
  • Maternal complications: bleeding during, eclampsia, placental hematoma retro, imminent work
  • Twin pregnancy
  • Patient under guardianship or trusteeship
  • Patient not speaking and writing French

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: A group of 20 pregnant patients.
20 patients referred for intrauterine spontaneous fetal death explored by MRI and autopsy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Recognition of anatomic cerebral structures evaluated by a common grid.
Time Frame: Before H 24 for MR. Bedore day 5 for autopsy.
Before H 24 for MR. Bedore day 5 for autopsy.

Secondary Outcome Measures

Outcome Measure
Time Frame
Recognition and mesurement of anatomic thoracic and abdominal structures by a common grid.
Time Frame: Before H24 for MR. Before day 5 for autopsy.
Before H24 for MR. Before day 5 for autopsy.
Recognition and mesurement of the placenta and umbilical cord.
Time Frame: Before H24 for IRM. Before day 5 for autopsy.
Before H24 for IRM. Before day 5 for autopsy.
Comparaison of quality criteria of both exams.
Time Frame: Before H24 for MRI. Before day 5 for autopsy.
Before H24 for MRI. Before day 5 for autopsy.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

May 22, 2014

First Submitted That Met QC Criteria

May 27, 2014

First Posted (Estimate)

May 28, 2014

Study Record Updates

Last Update Posted (Actual)

June 15, 2017

Last Update Submitted That Met QC Criteria

June 13, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2012/169/HP

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spontaneous Intra Uterine Fetal Death

Clinical Trials on Comparaison between MR and autopsy in the macroscopic evaluation of intra uterine death.

3
Subscribe